Under the definitive merger agreement, which was unanimously approved by both companies’ board of directors, CHS will pay Health Management $3.9 billion in cash and stock. CHS valued Health Management’s stock at $13.78 per share. CHS will also assume $3.7 billion of Health Management’s debt.
Continue on to full article.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
